CNS and Chronic Drug Trials: New Cardiac Safety Requirements Webinar Replay
For long-term CNS drugs, blood pressure evaluation has become a critical consideration to establish the potential risk for stroke or other cardiovascular diseases. Blood pressure has also been implicated as a risk factor for neurological disease states as the brain is a frequent target of hypertension-induced damage. The link between blood pressure and brain pathology is mounting as studies have shown a correlation between blood pressure and CNS disorders such as dementia or Alzheimer’s, and a number of high-profile CNS drugs have been shown to have a significant impact on blood pressure.
Watch this webinar replay featuring experts from Clario as they discuss the cardiac safety requirements (BP & ECG) for CNS and chronically administered drugs.
The speakers will take a closer look at:
- The regulatory, scientific and technological evolutions in blood pressure and how these have impacted clinical trial design
- The strengths and challenges of blood pressure modalities will be assessed for various study types, with a focus on ABPM per the draft guidance